Cytokinetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CEORobert I. Blum
CEORobert I. Blum
Employees498
Employees498
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded1997
Founded1997
Employees498
Employees498
CYTK Key Statistics
Market cap3.65B
Market cap3.65B
Price-Earnings ratio-5.75
Price-Earnings ratio-5.75
Dividend yield—
Dividend yield—
Average volume2.17M
Average volume2.17M
High today$31.99
High today$31.99
Low today$29.83
Low today$29.83
Open price$29.94
Open price$29.94
Volume1.79M
Volume1.79M
52 Week high$61.38
52 Week high$61.38
52 Week low$29.31
52 Week low$29.31
CYTK News
TipRanks 5d
Top Executive Sells Thousands of Cytokinetics Shares!New insider activity at Cytokinetics ( (CYTK) ) has taken place on May 21, 2025. Confident Investing Starts Here: Easily unpack a company's performance with T...
Simply Wall St 6d
The Cytokinetics, Incorporated Analysts Have Been Trimming Their Sales ForecastsToday is shaping up negative for Cytokinetics, Incorporated ( ) shareholders, with the analysts delivering a substantial negative revision to this year's foreca...
Analyst ratings
86%
of 22 ratingsBuy
86.4%
Hold
13.6%
Sell
0%
People also own
Based on the portfolios of people who own CYTK. This list is generated using Robinhood data, and it’s not a recommendation.